- Home
- LGO vs LXEO Comparison
LGO vs LXEO Comparison
Compare LGO & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- LXEO
- Stock Information
- Founded
- LGO 1988
- LXEO 2017
- Country
- LGO Canada
- LXEO United States
- Employees
- LGO N/A
- LXEO N/A
- Industry
- LGO
- LXEO
- Sector
- LGO
- LXEO
- Exchange
- LGO Nasdaq
- LXEO Nasdaq
- Market Cap
- LGO 91.0M
- LXEO 93.9M
- IPO Year
- LGO 2007
- LXEO 2023
- Fundamental
- Price
- LGO $1.23
- LXEO $3.91
- Analyst Decision
- LGO Strong Buy
- LXEO Strong Buy
- Analyst Count
- LGO 1
- LXEO 5
- Target Price
- LGO $3.70
- LXEO $16.60
- AVG Volume (30 Days)
- LGO 105.3K
- LXEO 719.7K
- Earning Date
- LGO 08-07-2025
- LXEO 08-11-2025
- Dividend Yield
- LGO N/A
- LXEO N/A
- EPS Growth
- LGO N/A
- LXEO N/A
- EPS
- LGO N/A
- LXEO N/A
- Revenue
- LGO $110,968,000.00
- LXEO N/A
- Revenue This Year
- LGO $23.62
- LXEO N/A
- Revenue Next Year
- LGO $41.27
- LXEO N/A
- P/E Ratio
- LGO N/A
- LXEO N/A
- Revenue Growth
- LGO N/A
- LXEO N/A
- 52 Week Low
- LGO $1.12
- LXEO $1.45
- 52 Week High
- LGO $2.84
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- LGO 37.17
- LXEO 55.22
- Support Level
- LGO $1.25
- LXEO $3.62
- Resistance Level
- LGO $1.34
- LXEO $4.29
- Average True Range (ATR)
- LGO 0.07
- LXEO 0.45
- MACD
- LGO -0.00
- LXEO 0.04
- Stochastic Oscillator
- LGO 0.00
- LXEO 58.68
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.